Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.14
-0.06 (-1.15%)
At close: Aug 7, 2025, 4:00 PM
5.22
+0.08 (1.56%)
Pre-market: Aug 8, 2025, 5:26 AM EDT
Satixfy Communications Employees
Ardelyx had 395 employees as of December 31, 2024. The number of employees increased by 128 or 47.94% compared to the previous year.
Employees
395
Change (1Y)
128
Growth (1Y)
47.94%
Revenue / Employee
$977,585
Profits / Employee
-$142,752
Market Cap
1.24B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 395 | 128 | 47.94% |
| Dec 31, 2023 | 267 | 134 | 100.75% |
| Dec 31, 2022 | 133 | 47 | 54.65% |
| Dec 31, 2021 | 86 | -43 | -33.33% |
| Dec 31, 2020 | 129 | 41 | 46.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARDX News
- 3 days ago - Ardelyx, Inc. (ARDX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Ardelyx Announces Changes to the Executive Leadership Team - GlobeNewsWire
- 3 days ago - Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 17 days ago - Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 - GlobeNewsWire
- 2 months ago - Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer - GlobeNewsWire
- 2 months ago - Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 - GlobeNewsWire
- 3 months ago - Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference - GlobeNewsWire
- 3 months ago - Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty - Seeking Alpha